X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3860) 3860
Publication (141) 141
Book Chapter (14) 14
Reference (14) 14
Book Review (7) 7
Magazine Article (4) 4
Web Resource (4) 4
Conference Proceeding (3) 3
Dissertation (3) 3
Book / eBook (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (2758) 2758
male (2169) 2169
rats (2074) 2074
catalepsy - chemically induced (1863) 1863
catalepsy (1819) 1819
humans (1150) 1150
mice (1090) 1090
pharmacology & pharmacy (913) 913
neurosciences (877) 877
motor activity - drug effects (696) 696
haloperidol (674) 674
haloperidol - pharmacology (612) 612
behavior, animal - drug effects (600) 600
dose-response relationship, drug (577) 577
female (517) 517
dopamine (499) 499
index medicus (423) 423
rats, wistar (416) 416
rats, inbred strains (415) 415
catalepsy - physiopathology (410) 410
antipsychotic agents - pharmacology (402) 402
rats, sprague-dawley (387) 387
stereotyped behavior - drug effects (380) 380
time factors (364) 364
rat (354) 354
catalepsy - drug therapy (318) 318
schizophrenia (302) 302
psychiatry (295) 295
brain (279) 279
haloperidol-induced catalepsy (273) 273
dopamine - metabolism (271) 271
apomorphine - pharmacology (267) 267
parkinson's disease (251) 251
drug interactions (249) 249
brain - metabolism (243) 243
disease models, animal (234) 234
brain - drug effects (221) 221
corpus striatum - drug effects (201) 201
receptors (200) 200
corpus striatum - metabolism (199) 199
striatum (194) 194
behavioral sciences (192) 192
parkinsons-disease (183) 183
basal ganglia (179) 179
dopamine antagonists - pharmacology (179) 179
drug synergism (179) 179
receptors, dopamine - drug effects (172) 172
morphine - pharmacology (168) 168
avoidance learning - drug effects (166) 166
neuroleptics (160) 160
body temperature - drug effects (158) 158
serotonin (155) 155
catalepsy - metabolism (154) 154
drugs (152) 152
induced catalepsy (151) 151
clozapine (149) 149
clinical neurology (148) 148
receptor (147) 147
catalepsy - prevention & control (144) 144
rat-brain (141) 141
nucleus-accumbens (139) 139
morphine (137) 137
structure-activity relationship (133) 133
apomorphine (130) 130
piperazines - pharmacology (121) 121
catalepsy - genetics (118) 118
dopamine - physiology (117) 117
behavior (115) 115
analgesia (114) 114
chemistry, medicinal (113) 113
5-ht (112) 112
brain chemistry - drug effects (110) 110
biomedicine (109) 109
neurons (109) 109
amphetamine - pharmacology (106) 106
catalepsy - psychology (106) 106
locomotion (104) 104
amphetamine (103) 103
medicine, research & experimental (102) 102
piperidines - pharmacology (102) 102
drug tolerance (101) 101
pharmacology (101) 101
benzazepines - pharmacology (99) 99
receptors, dopamine d2 - metabolism (99) 99
mice, inbred c57bl (98) 98
motor activity - physiology (96) 96
antipsychotic (94) 94
haloperidol - toxicity (94) 94
locomotor activity (94) 94
antagonist (92) 92
in-vivo (92) 92
dopamine d2 receptor antagonists (91) 91
analysis of variance (90) 90
dopamine agonists - pharmacology (90) 90
mice, inbred strains (88) 88
dronabinol - pharmacology (87) 87
dopamine antagonists (84) 84
injections, intraventricular (83) 83
locomotion - drug effects (83) 83
rodents (83) 83
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3462) 3462
Russian (197) 197
French (63) 63
Japanese (54) 54
German (40) 40
Italian (22) 22
Spanish (12) 12
Chinese (11) 11
Polish (11) 11
Czech (4) 4
Ukrainian (3) 3
Bulgarian (2) 2
Danish (1) 1
Finnish (1) 1
Norwegian (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
10/2011
Objective : To assess the anticataleptic and antiepileptic activity of leaves of Mucuna pruriens in albino rats. Materials and Methods : Haloperidol-induced... 
epilepsy | Mucuna pruriens | Catalepsy | dopamine
Web Resource
Neuropharmacology, ISSN 0028-3908, 03/2013, Volume 66, pp. 158 - 169
Group III metabotropic glutamate (mGlu) receptors are localized in presynaptic terminals within basal ganglia (BG) circuitry that become hyperactive due to... 
Striatum | Basal ganglia | Akinesia | Rat | Lu AF21934 | l-DOPA-induced dyskinesia | Electrophysiology | HIGH-FREQUENCY STIMULATION | NEUROLOGICAL DISEASES | NEUROSCIENCES | RAT MODEL | STRIATAL SYNAPTIC PLASTICITY | MEDIATED MODULATION | SUBTHALAMIC NUCLEUS | UNILATERAL 6-HYDROXYDOPAMINE LESIONS | PHARMACOLOGY & PHARMACY | DEEP BRAIN-STIMULATION | L-DOPA-induced dyskinesia | MOLECULAR-MECHANISMS | Anilides - therapeutic use | Catalepsy - drug therapy | Synaptic Transmission - physiology | Excitatory Amino Acid Agonists - therapeutic use | Receptors, Metabotropic Glutamate - physiology | Male | Aminobutyrates - pharmacology | Anilides - pharmacokinetics | Parkinson Disease - drug therapy | Oxidopamine | Aminobutyrates - therapeutic use | Excitatory Postsynaptic Potentials - drug effects | Dose-Response Relationship, Drug | Excitatory Postsynaptic Potentials - physiology | Haloperidol - antagonists & inhibitors | Allosteric Regulation - physiology | Dyskinesia, Drug-Induced - drug therapy | Catalepsy - chemically induced | Synaptic Transmission - drug effects | Haloperidol - pharmacology | Disease Models, Animal | Allosteric Regulation - drug effects | Aminobutyrates - agonists | Levodopa - pharmacology | Cyclohexanecarboxylic Acids - therapeutic use | Phosphinic Acids - agonists | Levodopa - therapeutic use | Phosphinic Acids - therapeutic use | Rats | Excitatory Amino Acid Agonists - pharmacology | Rats, Sprague-Dawley | Drug Synergism | Animals | Cyclohexanecarboxylic Acids - pharmacology | Levodopa - adverse effects | Phosphinic Acids - pharmacology | Anilides - pharmacology | Excitatory Amino Acid Agonists - pharmacokinetics | Cyclohexanecarboxylic Acids - pharmacokinetics | Receptors, Metabotropic Glutamate - agonists | Receptors, Metabotropic Glutamate - antagonists & inhibitors | Physiological aspects | Phenols | Amino acids | Parkinson's disease | Glutamate | Drug therapy | 6-Hydroxydopamine | Phosphinic Acids | Excitatory Amino Acid Agonists | Allosteric Regulation | Catalepsy | Haloperidol | Aminobutyrates | Cellular Biology | Synaptic Transmission | Receptors, Metabotropic Glutamate | Parkinson Disease | Anilides | Life Sciences | Excitatory Postsynaptic Potentials | Cyclohexanecarboxylic Acids | Dyskinesia, Drug-Induced | Levodopa
Journal Article
Journal Article
08/2007
Neuroleptic drugs used in the treatment of schizophrenia and other affective disorders are known to produce extrapyramidal side effects. Catalepsy induced by... 
haloperidol | Catalepsy | Ocimum sanctum
Web Resource
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 8/2010, Volume 107, Issue 33, pp. 14845 - 14850
The direct and indirect pathways of the basal ganglia have been proposed to oppositely regulate locomotion and differentially contribute to pathological... 
Locomotion | Receptors | Basal ganglia | Neurons | Catalepsy | Antipsychotic agents | Cocaine | Behavioral neuroscience | Genotypes | Dyskinesia | DARPP-32 | Striatopallidal | Striatonigral | Locomotor behavior | basal ganglia | DOPA-INDUCED DYSKINESIA | NEUROTRANSMISSION | MULTIDISCIPLINARY SCIENCES | COCAINE | MODEL | striatopallidal | STRIATOPALLIDAL NEURONS | locomotor behavior | MICE | striatonigral | D1 RECEPTOR | PARKINSONS-DISEASE | Immunohistochemistry | Motor Activity - physiology | Dyskinesia, Drug-Induced - physiopathology | Dopamine and cAMP-Regulated Phosphoprotein 32 - genetics | Motor Activity - drug effects | Male | Neurons - cytology | Green Fluorescent Proteins - genetics | Corpus Striatum - cytology | Corpus Striatum - metabolism | Catalepsy - physiopathology | Neurons - classification | Neuronal Plasticity - physiology | Catalepsy - chemically induced | Long-Term Potentiation - physiology | Female | Neurons - metabolism | Dyskinesia, Drug-Induced - etiology | Green Fluorescent Proteins - metabolism | Synaptic Potentials - physiology | Dopamine Uptake Inhibitors - pharmacology | Mice, Inbred C57BL | Mice, Transgenic | Levodopa - toxicity | Dopamine and cAMP-Regulated Phosphoprotein 32 - metabolism | Mice, Knockout | Cocaine - pharmacology | Animals | Dopamine and cAMP-Regulated Phosphoprotein 32 - physiology | Fluorescent Antibody Technique | Dopamine Agents - toxicity | Mice | Haloperidol - toxicity | Human locomotion | Health aspects | Motor ability | Drugs | Animal models | Neuroleptics | Parkinson's disease | Neurodegenerative diseases | Haloperidol | spiny neurons | Signal transduction | Clonal deletion | Neostriatum | DARPP-32 protein | Levodopa | Locomotor activity | Movement disorders | Biological Sciences
Journal Article
Journal Article